A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer
about
RhoA as a mediator of clinically relevant androgen action in prostate cancer cellsRho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and diseaseEmerging data on androgen receptor splice variants in prostate cancerMST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.VAV3 mediates resistance to breast cancer endocrine therapy.Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.VAV3 oncogene expression in colorectal cancer: clinical aspects and functional characterization.PH motifs in PAR1&2 endow breast cancer growth.Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survivalNovel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.Deregulation of Rho GTPases in cancerThe Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells.Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts.Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.Evaluation of Vav3.1 as prognostic marker in endometrial cancer
P2860
Q24618899-BE58F238-18EB-4708-BF86-49CAA8A5FC7BQ26853181-85CB2078-B9C6-4BB7-892C-C2F04D871E0EQ28077830-4E68D97E-14EA-48FA-BFAB-E88379CDB524Q30009013-9A44641B-14B8-41D5-A67B-49A0D2AE1844Q33827037-9A32A04F-E256-435D-A90A-3442EB39A3E6Q33862462-B1636451-ECEE-4F6E-B732-04EE734A5EEAQ35198158-27EC428E-3E5E-4BC3-B4FD-4F7B3CF926A6Q36357012-C2F9C212-B4C2-41FA-A0E5-44AF3D1180B3Q36454548-A208BABB-0F7E-4B3A-AE0E-173E49ABA282Q36635865-52BBAD9E-EA69-48DF-B52F-8F42F7961F7FQ36915415-D596B948-041B-4E6F-A2C7-15356682A27FQ37214445-1D8F8C9C-62B4-4479-8294-35FBE7047779Q37424400-7E720204-5125-4CB0-97E6-74475418237EQ37519616-982E1A46-6B9A-4393-A48D-EDD8F002B8CEQ38552283-E318DB20-088A-431B-B7AF-78062EA9A2DCQ38945177-A18C9EED-F0D3-4A5E-993B-B12153038EE4Q38971323-B6BA1CE9-2EC6-44D4-87C7-1C9149C01A06Q39114221-CA3CBAC9-7EC8-4578-9D13-95CB31FDE5ECQ39205279-3BF27DE0-7468-45D6-874C-0BAC66E54EDAQ52683959-585846D9-A469-46BB-B93A-EB08B4FFDD8AQ57141071-7AEA8F69-0BA0-4E23-8AA9-8278BA71F709
P2860
A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel nuclear role for the V ...... oactivation in prostate cancer
@ast
A novel nuclear role for the V ...... oactivation in prostate cancer
@en
type
label
A novel nuclear role for the V ...... oactivation in prostate cancer
@ast
A novel nuclear role for the V ...... oactivation in prostate cancer
@en
prefLabel
A novel nuclear role for the V ...... oactivation in prostate cancer
@ast
A novel nuclear role for the V ...... oactivation in prostate cancer
@en
P2093
P2860
P356
P1433
P1476
A novel nuclear role for the V ...... oactivation in prostate cancer
@en
P2093
C D Fahrenholtz
K L Burnstein
P2860
P2888
P304
P356
10.1038/ONC.2011.273
P407
P577
2011-07-18T00:00:00Z